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Abstract 
Background: Aseptic loosening (AL) of hip prosthesis presents inflammation and pain as sign and symptom similarly 
to arthritis pathologies. Still, the immune and innervation profiles in hip AL remain unclear and their interplay is poorly 
explored. Herein, local tissue inflammatory response, sensory and sympathetic innervation as well as associated local 
mediators were assessed in hip joint microenvironment underlying AL and compared to osteoarthritis (OA).
Methods: Histopathological analysis, immune cells (macrophages, T, B cells and PMNs) as well as sensory and sym‑
pathetic nerve fibers (SP+, CGRP+, TH+) distribution and profiles were analyzed on tissues retrieved from patients with 
failed hip prostheses due to AL (n = 20) and hip OA (n = 15) by immunohistochemistry. Additionally, transcriptional 
levels of pro‑inflammatory cytokines (TNF‑α, IL‑1β, IL‑6, IL‑12a, iNOS), anti‑inflammatory cytokine (IL‑10), osteoclastic 
factor (RANKL) and bone remodeling factor (TGF‑β1) were locally evaluated by qRT‑PCR. Serum TGF‑β1 levels were 
assessed preoperatively by ELISA.
Results: Histopathological analysis revealed that tissues, aseptic interface membranes of AL patients had distinct 
tissue architecture and immune cells profile when compared to OA synovial tissues. Macrophages, T cells and B cells 
showed significant differences in tissue distribution. In OA, inflammation is mostly confined to the vicinity of synovial 
membrane while in AL macrophages infiltrated throughout the tissue. This differential immune profile is also accom‑
panied with a distinct pattern of sensory and sympathetic innervation. Importantly, in AL patients, a lack of sympa‑
thetic innervation aseptic interface membranes without compensation mechanisms at cellular levels was observed 
with simultaneous reorganization of sensorial innervation. Despite the different histopathological portrait, AL and OA 
patients exhibited similar transcriptional levels of genes encoding key proteins in local immune response. Neverthe‑
less, in both pathologies, TGF‑β1 expression was prominent in sites where the inflammation is occurring. However, at 
systemic level no differences were found.
Conclusion: These findings indicate that AL patients exhibit different local inflammatory response and innervation 
signatures from OA patients in hip joint. These insights shed the light on neuro‑immune interplay in AL and highlight 
the need to better understand this crosstalk to unravel potential mechanisms for targeted‑therapies to improve hip 
joint lifetime and treatment.
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Background
Osteoarthritis (OA) has long been considered a cartilage 
driven “wear and tear” disease that may lead to hip joint 
failure [1, 2]. The pain and diminished hip joint motion 
induced by OA may be effectively treated through pri-
mary hip replacement [3, 4]. Unfortunately, hip replace-
ment is not a permanent solution as prostheses often 
fail 15–25  years after primary surgery, mostly due to 
aseptic loosening (AL), infection and dislocation [5, 6]. 
Other therapeutic solutions are then urgently required to 
expand implants’ lifetime.
Inflammation is common to AL and OA [1, 7, 8]. 
Immune cells and cytokines have been previously 
reported in both clinical scenarios [8–11]. Synovial 
inflammation is often observed in OA patients and is 
frequently characterized by the infiltration of specific 
immune cell populations, such as macrophages, T cells 
and mast cells, as well as by the expression of pro-inflam-
matory cytokines, as Tumor necrosis factor-α (TNF-α) 
and interleukin-1β (IL-1β) [7]. Nevertheless, these find-
ings were mostly described in studies focusing on the 
knee or in studies combining data from both knee and 
hip, without anatomical discrimination [7]. On the other 
hand, periprosthetic joint inflammation is commonly 
known as a complex local biological response that takes 
place on synovial membrane-like interface tissues, trig-
gered by implant released by-products (particles and 
ions) [12–15]. Of note, the nature, size and amount of 
released particles are recognized to define the inflamma-
tory profile [13–16]. While polymeric particles such as 
polyethylene (PE) and polymethylmethacrylate (PMMA) 
are often associated with macrophage mediated foreign 
body reaction and tissue fibrosis, high levels of metallic 
particles and ions have been demonstrated to promote 
tissue necrosis and lymphocyte-driven responses [17].
Pain is one of the clinical features observed in both 
AL and OA conditions [18, 19]. Innervation profile is 
mostly studied in the context of arthritic diseases but 
not in the presence of implantable biomaterials. Patients 
and animal studies highlighted innervation of syno-
vial tissues as a possible player in the pain process and, 
based on anatomical mapping, suggested a coupling of 
innervation and inflammation in osteoarthritic synovial 
tissues [20, 21]. It is well documented that both sym-
pathetic, tyrosine-hydroxylase (TH)+ or neuropeptide 
Y (NPY)+, and sensory nerve fibers, substance P (SP)+ 
and calcitonin gene related peptide (CGRP)+, are pre-
sent in OA synovial tissue and grow towards cartilage 
along blood vessels [21]. On the other hand, so far, two 
studies addressed the innervation of the interface mem-
branes surrounding AL hip prostheses [19, 22]. Unfor-
tunately, the data is still unclear. Niissalo et al. reported 
that the synovial membrane-like interface did not contain 
C-sensory peptidergic or sympathetic neural structures 
while Ahmed et  al. identified sympathetic nerve fibers 
in these interface membranes [19, 22]. Thus, innervation 
profile and its possible association with periprosthetic 
joint inflammation, triggered by prosthetic debris in AL 
scenario, should be revised. Furthermore, the compari-
son of the inflammatory versus innervation profiles of AL 
and OA has never been examined and requires further 
investigation. In this study, the immune and innervation 
profiles of AL and OA were addressed dissecting local 




Centro Hospitalar São João ethics committee approved 
this study and all patients consented to the use of their 
tissue and blood for research purposes. The followed 
procedures were in accordance with the Helsinki Decla-
ration of 1975, as revised in 2000. Samples from synovial 
membrane-like interface tissue/aseptic interface mem-
brane were collected from twenty patients during hip 
revision surgeries due to AL of hip prostheses. All revised 
hips had a metal-on-polyethylene (MoP) coupling, eleven 
out twenty cemented and bone defects were classified 
according to the Paprosky classification [23]. Relevant 
clinical information is summarized in Table  1. Infec-
tion, recurrent dislocation and periprosthetic fracture 
were considered exclusion criteria in the aseptic loosen-
ing group. Osteoarthritic synovial tissues were collected 
from 15 patients undergoing primary hip replacement 
surgeries for primary OA. OA patients were classified 
for OA severity according Tönnis OA grade [24] and pre-
sented scores from moderate (2) to severe (3). The clinical 
information of these patients is summarized in Table  2. 
For both OA and AL groups, the same orthopedic team 
performed the collection of tissue samples. Previously to 
surgery, blood was collected and leukograms and plain 
radiographies were registered.
Immediately after excision, both OA synovial tissues 
and aseptic interface tissues were split. Half of the tis-
sue was immersed in formalin for further histological 
analysis, while dry ice was used to freeze the remaining 
tissue until storage at −80 °C. No more than 4 h elapsed 
between tissue collection and storage.
Histochemistry and immunostaining
Half of collected tissues were formaldehyde-fixed paraffin 
embedded and cross-sections of 3 μm thickness were cut. 
Contiguous sections were stained with hematoxylin & 
eosin (H&E) and Masson’s trichrome (MT). For immuno-
histochemistry, tissue sections were deparaffinized and 
rehydrated before heat induced antigen retrieval (98  °C, 
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10  mM citrate buffer, pH 6.0). Endogenous peroxidases 
were blocked using 3  % H2O2 and non-specific binding 
sites were blocked using Background Block (Cell Marque, 
USA), previously to the incubation with antibody dilu-
ent 1 % BSA (negative control) or with primary antibod-
ies: anti-CD20 (clone L26, dilution 1:100, Cell Marque, 
USA), anti-CD163 (clone MRQ-26, dilution 1:150, Cell 
Marque, USA), anti-CD68 (clone 514H12, dilution 1:100, 
Novocastra, UK), anti-HLA-DR (clone TAL1B5, dilution 
1:5000, Abcam, USA) and anti-CD3 (clone PS1, dilution 
1:100, Biocare Medical, USA). After primary antibody 
incubation, tissue sections were incubated with Bright-
Vision Poly-HRP-Anti Mouse/Rabbit/Rat IgG (Immuno-
logic, the Netherlands) and then revealed using DAB Plus 
Substrate System (Thermo Scientific, USA), before hema-
toxylin counterstaining. The specificity of immunostain-
ings of CD20, CD163, CD68, HLA-DR and CD3 was 
confirmed using human spleen as positive control. For 
immunofluorescence studies, tissue section were depar-
affinized and antigen retrieval of rehydrated sections 
was performed using Proteinase K (0.2  mg/mL in PBS) 
for NF200 immunostaining and incubated for 20 min at 
98  °C in Citrate buffer (pH 6.0), or TE Buffer (pH 9.0) 
for SP and CGRP staining, respectively. After quench-
ing endogenous fluorescence with 0.1 % sodium borohy-
dride and 100 mM NH4Cl, sections were incubated with 
blocking buffer (10 % FBS, 1 % BSA, 0.2 % Triton X-100). 
Table 1 Clinical data from aseptic loosening patients
Aseptic loosening 
case number











1 79 M MoP Cemented 13 Acetabular 2B
2 61 F MoP Cemented 24 Acetabular 2A
3 74 F MoP Cemented 23 Acetabular 2B
4 86 F MoP Cemented 46 Acetabular 2B
5 50 F MoP Uncemented 56 Acetabular 
femoral
3A1 Yes
6 79 F MoP Cemented 96 Acetabular 3A
7 73 M MoP Cemented 108 Acetabular 3A
8 69 F MoP Cemented 117 Acetabular 2C
9 74 M MoP Cemented 120 Acetabular 
femural
2A1
10 77 M MoP Uncemented 120 Acetabular 
femoral
2B1
11 45 F MoP Uncemented 129 Acetabular 3A
12 73 F MoP Uncemented 130 Acetabular 1 Yes
13 63 F MoP Cemented 138 Acetabular 3A
14 75 M MoP Cemented 144 Acetabular 3A
15 62 F MoP Uncemented 153 Acetabular 2C
16 53 F MoP Uncemented 156 Acetabular 2A
17 86 F MoP Cemented 168 Acetabular 
femoral
2A1
18 71 F MoP Uncemented 204 Acetabular 1
19 82 F MoP Uncemented 216 Acetabular 1 Yes
20 75 M MoP Uncemented 240 Acetabular 1 Yes
Table 2 Clinical data from osteoarthritis patients
Osteoarthritis
case number
Age Gender OA severity (tonnis
classification)
1 79 F 2
2 45 F 3
3 54 F 3
4 80 F 3
5 55 M 3
6 49 F 2
7 76 M 3
8 51 F 2
9 56 F 3
10 71 M 3
11 74 F 3
12 83 M 3
13 37 F 3
14 74 M 3
15 66 M 2
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Primary antibody rabbit anti-human neurofilament 
heavy subunit (NF200) (dilution 1:1000, Abcam, USA), 
anti-Substance P (dilution 1: 1000, Millipore, USA), anti-
TH (dilution 1:100, Millipore, USA), anti-CGRP (dilution 
1:4000, Sigma-Aldrich, USA) or blocking buffer (negative 
control) was applied overnight at 4  °C. For signal detec-
tion, tissue sections were incubated with anti-rabbit 
Alexa Fluor 568 antibody (dilution 1:1000, Life Tech-
nologies, USA), incubated with DAPI and then mounted 
with Fluoroshield Mounting Medium (Abcam, USA). 
The specificity of immunostainings for NF200, Substance 
P, TH and CGRP was confirmed using a specimen of 
human Morton’s neuroma as positive control.
Semi‑quantitative histopathological evaluation
In order to characterize synovial microenvironment, tis-
sues were semi-quantified considering the total immuno-
reactive area and scored into four categories: absent (0), 
present (1), frequent (2) or abundant (3), according to the 
histological grading system illustrated in the Additional 
file 1: Figure S1 (tissue reaction), Additional file 2: Figure 
S2 (prosthetic debris accumulation) and Additional file 3: 
Figure S3 (immune cells distribution), similarly to the 
methodology followed by others [25, 26].
Structural changes, fibrosis and necrosis in OA synovial 
tissues and aseptic interface tissues were evaluated after 
H&E and MT staining. The thickening/hyperplasia and 
increased villi of synovial membrane were assessed in OA 
patients. The accumulation of polymeric, ceramic and 
metallic particles was assessed in synovial membrane-
like interface tissues. A polarized filter was used to detect 
polymeric particles. Ceramic and metallic particles were 
studied through scanning electron microscopy (SEM) 
and their elemental composition assessed by energy dis-
persive spectroscopy (EDS). Additionally, a phase con-
trast filter (Ph3) was used with an optical microscope to 
ease the detection of clusters of ceramic or metallic par-
ticles in histological slices, allowing a deep study of the 
interaction between particles and cells. The infiltration of 
target immune cell populations, identified by immuno-
histochemistry, was determined regarding the presence 
of macrophages (CD68+ cells), T cells (CD3+ cells) and B 
cells (CD20+ cells). The semi-quantification of polymor-
phonucleated cells (PMNs) was performed after PMNs 
identification as these cells have a lobed nucleus while 
multinucleated giant cells (GC) were detected due to 
their bigger size, multiples nucleus and CD68+ labeling.
Tissue samples retrieved from five out thirty-five 
patients (4/15 OA and 1/20 AL) were excluded from 
histopathological evaluation because they do not cor-
respond to OA synovial tissue or aseptic interface tis-
sue. H&E, MT and immunohistochemistry slices were 
analyzed using a light microscope Olympus CX31 while 
immunofluorescence, polarized light and phase contrast 
Ph3 images were captured on Carls Zeiss Axiovert 200 
inverted microscope.
Gene expression analysis
Synovial tissues were homogenized in liquid nitrogen 
using a mortar and pestle to preserve RNA integrity. 
RNA was extracted and purified using TRIzol (Invit-
rogen, UK) and Direct-zol™ RNA MiniPrep (ZYMO 
Research, USA), according to the manufacturers’ 
instructions. The amount and quality of extracted RNA 
were evaluated by Nanodrop ND-1000 (Thermo Fisher 
Scientific, USA) and running RNA samples in a 2  % 
agarose gel. The transcriptional levels of pro-inflamma-
tory cytokines (TNF-α, IL-1β, IL-6, IL-12a and iNOS), 
anti-inflammatory cytokine (IL-10), osteoclastic factor 
(RANKL) and bone remodeling factor (TGF-β1) were 
evaluated by quantitative real time PCR (qRT-PCR) 
in PCR iQ™5 system (Bio-rad, USA). All used primers, 
listed in Table  3, were optimized and melting curves 
of PCR products were evaluated to guarantee primers 
specificity. β2 microglobulin (B2  M) and β-actin were 
used as reference genes. Experiments were performed 
in triplicated. Relative gene expression levels were cal-
culated using the quantification cycle (Cq) method, 
according to MIQE guidelines [27]. Fourteen out thirty-
six cases (5/15 OA and 9/20 aseptic loosening) were 
excluded from gene expression analysis when average 
Cq for reference genes was above 26, to avoid bias in the 
evaluation of genes with later expression.
ELISA
Serum transforming growth factor β1 (TGF-β1) concen-
trations were measured using Quantikine® ELISA Kit for 
human TGF-β1 (R&D Systems, USA), according to the 
manufacturer’s protocol. Cytokine concentration was cal-
culated against a standard curve.
Statistical analysis
Statistical analysis was performed using SPSS 21.0 (SPSS 
Inc. Chicago, IL, USA). The level of significance was set 
at p  <  0.05 (*). Visual histogram analysis and Kolmogo-
rov–Smirnov test were used to evaluate the normal dis-
tribution of continuous variables (gene expression data, 
TGF-β1 plasma concentration and percentage of immune 
cells in blood). Accordingly, these variables were ana-
lyzed using Student’s t test or its non-parametric coun-
terpart, Mann–Whitney test. Tissue immune response 
and innervation was histologically classified in different 
grading categories and comparisons between aseptic 
interface tissues and OA synovial were done using Chi 
square test. All graphs were prepared using Prism soft-
ware (GraphPad software, San Diego, CA, USA).
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Results
Local immune responses in OA synovial tissues 
and synovial membrane‑like interface tissue
In this study, 15 patients underwent primary hip replace-
ment due to OA (Fig. 1a) and twenty hip implants were 
revised and their acetabular defects classified by X-ray 
imaging (Fig. 1b). Macroscopically, the collected synovial 
tissues at primary and revision surgeries were morpho-
logically distinct. Synovial surface was white and with 
diffuse papillary architecture (dashed black line, Fig. 1c, 
d) whereas synovial membrane-like interface tissues 
were highly fibrotic (Fig. 1e) or with greyish appearance 
(Fig. 1f ), in case of metallosis.
Semi-quantitative analysis of tissue organization and 
immune cell distribution in OA synovial tissue and asep-
tic interface tissues showed distinct local profiles. OA 
synovial membranes displayed a bicellular lining layer 
(LL) and a sublining layer (SLL) (Fig.  2a) enriched in 
blood vessels (black arrows) and collagen (Fig. 2b), as well 
as structural changes induced by synovial inflammation, 
such as synovial hyperplasia (Fig.  2c, d) and increased 
number of villi (Fig.  2e, f ). OA patients presented at 
least one sign of synovial inflammation (thickening or 
villi) but their magnitude was variable among patients 
(Fig. 2c, e). Synovial membrane-like interface tissues pre-
sented fibrotic stroma with increased collagen deposition 
(Fig. 2g, h) than OA synovial tissues (p = 0.001) and with 
some necrotic regions (Fig. 2i).
The accumulation of prosthetic debris in synovial 
membrane-like interface tissues was semi-quantified. 
Polymeric particles were just detected in 11/20 analyzed 
aseptic interface tissues (Fig.  3a) after tissue analysis 
under polarized light (Fig.  3b, c). No significant differ-
ence was found between AL patients with cemented and 
uncemented MoP bearings regarding the amount of poly-
meric particles entrapped in synovial membrane-like tis-
sues. Zirconia particles (ZrO2) were observed in almost 
all synovial membrane-like interface tissues retrieved 
from patients with loose cemented prostheses (Fig. 3d–f) 
and mainly phagocytized by macrophages or multinu-
cleated giant cells (Fig. 3g). Ph3 contrast filter eased the 
detection of ZrO2 particles (Fig. 3e, f ). White color par-
ticles under Ph3 filter were confirmed to be ZrO2 and 
to be organized in clusters of nanoparticles by SEM/
EDS (Fig.  3h, i). Intense deposition of metallic particles 
was just found in the four cases of metallosis that were 
patients with uncemented metal-back acetabular cups 
(Fig.  3j). Aseptic interface membranes with metallosis 
presented high deposition of metallic particles with con-
comitant macrophage infiltration (Fig. 3k), tissue fibrosis 
(Fig. 3l) and necrosis (Fig. 3m). Under Ph3 filter, metallic 
nanoparticles and haemoglobin presented violet and red 
color respectively, which allow distinguishing them from 
ZrO2 particles (Fig. 3n, o).
Immune cell distribution was studied in tissues from 
AL and OA patients. In AL, macrophages (CD68+ cells) 
were more abundant than in OA (p  =  0.007; Fig.  4a). 
While macrophages were often confined to lining layer 
in OA patients (Fig. 4b), signifficant macrophage infiltra-
tion was found in  synovial membrane-like interface tis-
sues  (Fig.  4c). In these tissues, co-localization between 
polymeric particles and macrophages was often found 
(Fig. 4d) and a similar pattern was observed in AL patients 
with cemented and uncemented MoP bearings. In AL 
patients, macrophages were the most prevalent immune 
cell population, even in metallosis cases, and in overall 
highly express M1 (HLA-DR; Fig.  3e) and M2 (CD163; 
Fig.  3f ) markers. Multinucleated giant cells in foreign 
body reaction setting were mostly found in synovial mem-
brane-like interface tissues (p = 0.037, Fig. 4g) surround-
ing big polymeric particles, likely PMMA, with ZrO2 
particles entrapped inside (Fig.  4h). T cells (CD3+ cells) 
(Fig. 4j), and B cells (CD20+ cells; Fig. 4l) in lower number, 
could be detected in the majority of tissues collected from 
Table 3 List of primers used for quantitative qRT-PCR analysis
Gene GenBank number Forward primer sequence (5′–3′) Reverse primer sequence (5′–3′)
B2M [NM_004048] CCAGCGTACTCCAAAGATTCAG AGTCAACTTCAATGTCGGATGG
β‑actin [NM_001101] TACCTCATGAAGATCCTCA TTCGTGGATGCCACAGGAC
IL‑1β [NM_000576] CTTCAGCCAATCTTCATT CACTGTAATAAGCCATCAT
IL‑6 [NM_000600] CAATCTGGATTCAATGAGGAGACT CTGTTCTGGAGGTACTCTAGGTAT
IL‑10 [NM_000572] GGAGAACCTGAAGACCCTCA TATAGAGTCGCCACCCTGAT
IL‑12a [NM_000882] TACCAGGTGGAGTTCAAG GTTCTTCAAGGGAGGATTT
iNOS [NM_000625] AATTGAATGAGGAGCAGGTC TCCTTCTTCGCCTCGTAA
TNF‑α [NM_000594] TCTCTCTAATCAGCCCTCTG TGCTACAACATGGGCTACAG
RANKL [NM_003701] GGATGGCTCATGGTTAGA CAAGAGGACAGACTCACTT
TGF‑β1 [NM_000660] CCTGGACACCAACTATTG CTTGCGGAAGTCAATGTA
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AL and OA patients (Fig. 4i, k), including AL patients with 
uncemented implants or signs of metallosis. Moreover, 
the number of PMNs was also low in both aseptic inter-
face membranes and OA synovial tissues. Overall, the 
immune cell populations addressed, namely macrophages, 
T cells, B cells and PMNs, in this study were most located 
in the vicinity of synovial membrane in OA patients, while 
in AL patients these cells were identified throughout the 
aseptic interface membranes.
Local innervation in AL and OA patients
Myelinated nerve fibers identified by NF200 immunore-
activity were detected in both synovial membrane-like 
interface tissues and OA synovial tissues. They were 
presented as single fibers (Fig. 5a, c) and were preferen-
tially arranged around blood vessels (Fig. 5c) particularly 
in tissue regions of reactive vascularization induced by 
immune responses underlying AL and OA. Alternatively, 
nerve fibers were also found in neurome-like structures 
(Fig.  5b, d) in both AL and OA patients. Sensory and 
sympathetic innervation, as seen by immunohistochemi-
cal markers of sensory nerve-associated peptides (SP and 
CGRP) and catecholaminergic marker of sympathetic 
neurons (TH), showed different pattern between OA 
patients and AL patients. TH immunoreactive nerve fib-
ers were observed in OA synovial tissues (Fig.  5f ) but 
not in synovial membrane-like interface tissues (Fig. 5g, 
h). SP and CGRP were found both in OA synovial tissues 
and synovial membrane-like interface tissues but showed 
different pattern. In OA synovial tissues, nerve fibers 
immunoreactive to SP and SGRP were observed mainly 
around blood vessels in the vicinity of synovial mem-
brane (Fig.  5j, n). In addition, a high number of cells in 
the OA synovial membrane also stained for TH, SP and 
CGRP (Fig. 5e, i, m). In synovial membrane-like interface 
tissues, the expression of SP and CGRP was also found in 
both nerve fibers and cells but with a broad distribution 
throughout the tissue (Fig. 5k, l, o, p).
Local gene expression profile
The expression levels of pro-inflammatory cytokines 
tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) 
and IL-6 were similar in aseptic interface tissues and OA 
synovial tissues (Fig. 6a–c). Inducible nitric oxide synthase 
(iNOS) and IL-12a expression levels were found to be low 
when compared with the TNF-α, IL-1β and IL-6 mRNA 
Fig. 1 Radiological and macroscopic tissue features of OA, AL and metallosis. a Anteroposterior X‑rays showing OA of the hip. b Failed metal‑on‑
polyethylene total hip joint due to AL. c, d Macroscopic images of OA synovial tissue collected at primary hip replacement. e Synovial membrane‑
like interface tissue retrieved at hip revision surgery due to AL. f Metallic debris accumulation in synovial membrane‑like tissue from AL patient with 
metallosis
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Fig. 2 Histological evaluation of tissues organization. a OA synovial tissue is composed by different cell types and matrixes organized in synovial 
lining layer (LL) and sublining layer (SLL). b Dense net of blood vessels (black arrows) was found in SLL together with loose connective tissue (blue 
stain). c Histological grading for synovial membrane thickening in OA. d Synovial membrane thickening (ST) with reactive neo vascularization. e His‑
tological grading for synovial villous expansion in OA. f OA synovial membrane presenting villous hypertrophy (SV). g Histological grading for tissue 
fibrosis. h Synovial membrane‑like interface tissue showing fibrosis characterized by intense deposition of collagen fibers (blue stain). i Histological 
grading for tissue necrosis. Masson’s trichrome (a, b, d, f, h) staining. Scale bars correspond to 500 μm (b, f, h), 200 μm (d) and 50 μm (a). Semi‑
quantitative histological evaluation of tissue architecture was performed in specimens retrieved from 11/15 OA and 19/20 AL patients. ***p < 0.001. 
Chi square test was used to compare OA and AL groups
(See figure on next page.) 
Fig. 3 Prosthetic debris accumulation in synovial membrane‑like tissues. a Histological grading for accumulation of polymeric particles (PP) in 
aseptic interface membranes. b PP surrounded by macrophages (brown cells). c Same section of (H) under polarized light showing birefringent PP. 
d Histological grading for deposition of ZrO2 particles in synovial membrane‑like interface tissues. e H&E image of aseptic interface membrane 
with intense deposition of ZrO2 particles (black arrows) using conventional light microscopy. f Same tissue region observed using Ph3 filter with 
white and bright particles corresponding to ZrO2 debris (white arrows). g Macrophages (brown cells) phagocytizing ZrO2 debris (black arrows). h SEM 
image of synovial membrane‑like interface tissues containing clusters (Z1) and sole (Z2) ZrO2 nanoparticles. i EDS analysis confirming the elemental 
composition of ZrO2 nanoparticles. j Histological grading for entrapment of metallic particles in tissues. k Macrophages (brown cells, CD68 + cells) 
with phagocytized metallic particles. l Metallic particles co‑localized with macrophages and high deposition of collagen (blue stain). m Necrosis 
(N) in regions of aseptic interface membranes with massive accumulation of metallic particles. n Tissue from an AL patient with metallosis showing 
metallic particles and erythrocytes. o Same tissue section shwoing bright metallic particles and erythrocytes but exhibited under Ph3 filter violet 
and red colors, respectively. H&E staining (e, m, n), polarized light (c), Ph3 filter (f, o), Masson’s trichrome (l) immunohistochemistry (b, g, k), SEM 
imaging (h) and EDS spectra (i). Scale bars correspond to 500 μm (e, m), 50 μm (b, k, l) and 20 μm (g, n, o). Semi‑quantitative histological evaluation 
was performed in tissues retrieved from 19/20 AL patients
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levels detected in AL and OA groups (Fig. 6d, e). Interest-
ingly, the anti-inflammatory cytokine IL-10 presented a 
tendency (p  =  0.084) to be higher expressed in synovial 
membrane-like tissues than in OA synovial tissues (Fig. 6f). 
Two genes involved in bone remodeling were evaluated: 
TGF-β1 and receptor activator of nuclear factor kappa-B 
ligand (RANKL). The mRNA levels of TGF-β1 were sig-
nificantly reduced (p =  0.038) in aseptic interface tissues 
when compared to OA synovial tissues (Fig. 6g). However, 
no differences between AL and OA patients were verified 
for RANKL (Fig. 6h) and no correlation was found between 
mRNA levels of RANKL and the bone defect type.
Fig. 5 Local tissue innervation in OA and AL patients. a–d NF200+ fibers (red) as sole fiber or organized in neurome‑like structures in OA synovial 
tissues as well as in aseptic interface membranes. e Synovial cells expressing TH (red). f TH+ fiber surround a blood vessel. g, h Nor fibrotic nor 
reactive tisue with giant cells presented positive labelling for TH. i SP+ cells in OA synovium membrane. j SP+ fibers and SP+ cells surrounding a 
blood vessel located at subintimia of OA synovial tissue. k, l In AL patients, SP+ fibers were just found in fibrotic regions. m CGRP+ cells in synovial 
membrane. n CGRP+ fibers along a blood vessel in OA synovial tissue. o, p Some cells expressing CGRP in aspetic interface tissue. red = NF200+ 
or TH+ or SP+ or CGRP+ , blue = cell nuclei, green = autofluorescence) Scale bars correspond to 50 μm (a, b, d, f, g, h, i, j, k, l, m, n, o, p), 200 μm 
(e) and 100 μm (c)
(See figure on previous page.) 
Fig. 4 Immune cells distribution in OA synovial tissues and aseptic interface membranes. a Histological grading for macrophage (CD68+ cells) 
infiltration in tissues. b In OA, macrophages (brown cells) were almost found at LL. c Intense macrophage (brown cells) infiltration was detected in 
synovial membrane‑like interface tissues. d In aseptic interface tissues, macrophages (brown cells) were often found surrounding or phagocytos‑
ing prosthetic debris such as polymeric particles (PP) and ZrO2 particles (black arrows). e HLA‑DR + cells—an M1 macrophage marker. f CD163+ 
cells—an M2 macrophage marker. g Histological grading for multinucleated giant cells in tissues h Multinucleated giant cells (GC) phagocytosing 
a big PP particle with ZrO2 particles (black arrows) entrapped inside. i Histological grading for T cells (CD3+ cells). j Perivascular T cells (brown cells) 
clusters in OA synovial tissue. k Histological grading for B cells (CD20+ cells). l B cells (brown cells) in lymphocyte aggregates around blood vessels 
but in lower number than T cells. m Histological grading for polymorphonucleated cells (PMNs). n Increased number of PMNs (black arrows) in 
synovial membrane‑like tissue with macrophages (brown cells, CD68+ cells). Masson’s trichrome staining (h) and immunohistochemistry (b, c, d, 
e, f, j, l, n). Scale bars correspond to 500 μm (b, c) and 50 μm (d, e, f, h, j, l, n). Semi‑quantitative histological evaluation was performed in synovial 
tissues retrieved from 11/15 OA and 19/20 AL patients. *p < 0.05, ***p < 0.001. Chi square test was used to compare OA and AL groups
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Local TGF‑β1 expression
In both AL and OA patients, TGF-β1 was detected in 
blood vessels endothelium cells (Fig.  7a), macrophages 
(Fig.  7b) and fibroblasts (Fig.  7c). Interestingly, differ-
ences in the pattern of TGF-β1 expression were found 
between AL patients and OA. Aseptic interface tissues 
presented a trend (p  =  0.1672) toward increased num-
ber of regions expressing TGF-β1 (Fig. 7d). In OA syno-
vial tissues, TGF-β1 was present in the sublining layer of 
synovial membrane (Fig.  7e), in aggregates of lympho-
cytes (Fig. 7F) and blood vessels. In synovial membrane-
like interface tissues, the distribution of TGF-β1-positive 
regions was heterogeneous (Fig. 7g, h).
Immune cells proportions and TGF‑β1 concentration 
in blood
The preoperative leukograms were analyzed and the con-
centration of TGF-β1 determined in plasma of both AL 
and OA patients. The percentage of circulating mono-
cytes in both groups tended to be similar (Fig. 8a). Inter-
estingly, the percentage of lymphocytes seemed to be low 
in AL patients but within the reference interval in OA 
group (Fig.  8b). Neutrophils did not present significant 
alterations compared with the reference values (Fig. 8c). 
Remarkably, the levels of TGF-β1 in serum were similar 
in both groups (Fig. 8d).
Discussion
AL and OA differences rely on tissue architecture, 
immune cell distribution, local TGF-β1 expression as 
well as sensory and sympathetic synovial innervation. 
On the other hand, both pathologies share identical 
inflammatory mediators mRNA profiles and similar TGF-
β1 concentrations in serum, as summarized in Fig. 9.
Synovial membrane-like interface tissues, present in 
the vicinity of loose prostheses, showed a macrophage-
driven chronic inflammation. This immune response is 
likely influenced by both OA inflammatory background 
and the presence of prosthetic debris, leading to significant 
changes of local TGF-β1 expression but not systemically.
Distinct tissue organization and immune cell distri-
bution were found in the tissues retrieved from the hip 
joint of AL and OA patients. OA synovial tissues pre-
sented signs of synovial inflammation (synovitis), such 
as synovial hyperplasia and villous hypertrophy, while 
aseptic interface membranes, formed after primary hip 
replacement, exhibited a particle-driven chronic inflam-
mation. Intense infiltration of macrophages (CD68+ 
cells) was observed in AL patients in comparison to OA 
synovial tissues. In synovial membrane-like interface tis-
sues retrieved from AL patients, macrophages were the 
predominant immune cell type and were involved in the 
phagocytosis of small particles (<10 μm) or encapsulating 
bigger polymeric particles as multinucleated giant cells, in 
line with previous works about the role of macrophages 
on AL [28]. Although PE particles, released by MoP pros-
theses, have been pointed out as AL catalyzers [29, 30], 
other types of particles may play a role on the pro-inflam-
matory microenvironment underlying osteolysis. Large 
amounts of metallic particles were observed in four out 
nine AL patients due to impingement of metallic compo-
nents of uncemented MoP bearings.
Ceramic ZrO2 particles, incorporated in bone cements 
for implants fixation as radiopacifier agent, were found 
Fig. 6 Gene expression profiles of cytokines in aseptic interface membrane and OA synovial tissues. Relative expression levels of genes of interest 
determined through qRT‑PCR and normalized by two reference genes, β‑actin and B2 M: a IL‑1β. b TNF‑α. c IL‑6. d iNOS. e IL‑12a. f IL‑10. g TGF‑
β1 h RANKL. Data of 10/15 OA patients and 11/20 AL patients are shown. Significant difference of TGF‑β1 expression between AL and OA groups 
(*p < 0.05). Mann–Whitney test was utilized to compare and analyze the obtainded data
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in synovial membrane-like interface tissues from all the 
patients with cemented prostheses. Light microscopy 
with Ph3 contrast filter and SEM/EDS analysis revealed 
that ZrO2 gradually migrate from cement particles 
(PMMA) to other regions of aseptic interface tissues in 
high number, namely after being phagocytized by mac-
rophages. ZrO2 particles were shown to be moderately 
toxic, activate macrophages, promote the expression of 
Fig. 7 TGF‑β1 expression in synovial membrane‑like interface tissues and OA synovial tissues. a TGF‑β1+ endothelial cells in aseptic interface 
tissue with metallosis. b TGF‑β1+ macrophages in synovial membrane‑like interface tissue. c TGF‑β1+ fibroblast in aseptic interface membrane. d 
Number of OA and AL patients classified with score from 0 to 3 regarding the presence of TGF‑β1 in tissue. e OA synovial membrane with positive 
labelling at sublining layer and endothelium (black arrows). f Lymphocyte aggregate in OA synovial tissue with positive cells for TGF‑β1. g Aseptic 
interface membrane presenting heterogenous TGF‑β1 labelling. h Multinucleated giant cell (GC) phagocytosing a polymeric particle (PP) with ZrO2 
particles inside (black clusters) with TGF‑β1+ endothelial cells in the vicinity. Scale bars correspond to 500 μm (g) and 50 μm (a, b, c, e, f, h). Data 
was collected for 11/15 OA patients and for 19/20 AL patients. Chi square test was used to compare OA and AL groups
Fig. 8 Pre‑operative evaluation of immune populations and TGF‑β1 in blood. Data regarding the percentage of the following immune population 
in leukocytes count: a Monocytes, b Lymphocytes and c Neutrophils. Data was collected for 14/15 OA patients and for 17/20 AL. Dashed lines repre‑
sent minimum and maximum reference values. d TGF‑β1 serum concentration was determined for 13/15 OA patients and for all 20 AL patients
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pro-inflammatory cytokines (TNF-α) and induce osteoly-
sis in vivo [31, 32]. Despite reported not toxic as metallic 
particles or studied as polymeric debris [12, 33, 34], ZrO2 
particles should not be neglected, as they are numerous, 
common and nano-sized with potential to unbalance 
inflammation towards osteolysis. It has been reported that 
particle-induced response is prone to drive macrophages 
towards M1 phenotype and that M1:M2 ratio was higher 
in synovial membrane-like interface tissue than in OA 
synovial tissues [35, 36]. However, macrophage polariza-
tion in joint tissues remains controversial. In this study, 
the density of polymeric, metallic or ZrO2 particles on 
Fig. 9 Overview of hip microenvironment in OA and AL
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aseptic interface tissues did not lead to local preferential 
macrophage polarization in M1 pro-inflammatory (HLA-
DR+) or M2 pro-regenerative phenotypes (CD163+) as 
both receptors were similarly expressed on macrophages. 
In addition to the involvement of macrophages and lym-
phocytes in local inflammatory response, preoperative 
leukograms suggested monocyte expansion and contrac-
tion of lymphoid population in AL group.
Cytokines expression profile was found similar in 
synovial membrane-like interface tissues and OA syno-
vial tissues, despite their distinct tissue architecture and 
immune cell distribution. The response of macrophages 
to prosthetic debris is believed to induce the produc-
tion of the pro-inflammatory markers such as TNF-α, 
IL-1β, IL-6, IL-12a, and iNOS [28, 34, 37]. However 
those genes revealed similar mRNA levels in AL and OA 
patients, which is in line with comparable studies [26, 30, 
38]. The changes in cytokine expression induced by AL 
seem to be controversial [25]. Reduced mRNA levels of 
IL-6 have also been described in aseptic interface mem-
branes [26] while IL-6 was found significantly increase in 
synovial fluid of AL patients [25, 30]. A trend for higher 
mRNA levels of the anti-inflammatory cytokine IL-10 
was observed in synovial membrane-like interface tissues 
in comparison to OA synovial tissues (p =  0.084). This 
result corroborates with other findings showing signifi-
cant increase of IL10 protein levels in synovial fluid and 
interface tissues of AL patients [25, 26, 30]. The up-regu-
lation of IL-10 in aseptic interface tissues may constitute 
an attempt to balance the pro-inflammatory microenvi-
ronment induced by prosthetic debris [39, 40].
Although RANKL is involved in osteoclastogenesis and 
osteolysis, similar mRNA levels were found in AL and OA 
patients, in agreement with other authors [26, 30, 38, 41]. 
In overall, identical pattern regarding the expression of 
cytokines was found in AL and OA patients. In the context 
of AL, no significant differences were registered between 
polyethylene-drive and metallosis cases as previously 
shown [42]. The expression of TGF-β1 mRNA in synovial 
membrane-like interface tissues was found significantly 
lower than in OA synovial tissues but local TGF-β1 immu-
nostaining suggested increased expression of this protein 
in AL patients in comparison to OA patients. These find-
ings corroborate the results presented by other authors 
that have also found increased TGF-β1 mRNA levels in 
OA cartilage [9, 43, 44] and augmented TGF-β1 expres-
sion in synovial membrane-like interface tissues [45]. In 
both AL and OA, TGF-β1+ labeling was prominent in 
sites where the inflammation is occurring and mostly 
expressed in macrophages, fibroblasts and endothelium 
cells. However, while in OA the TGF-β1+ cells were found 
in the region of synovial membrane, in AL, the distribu-
tion was more heterogeneous and throughout different 
tissue regions. These results suggest a possible association 
between TGF-β1 and the immune responses that under-
lie AL and OA. Despite a previous report indicates that in 
OA pathogenesis, TGF-β1 might have a pro-inflammatory 
effect by inducing fibroblasts to express TNF-α and IL-1β 
[46], its involvement in inflammatory response is not fully 
understood. Although the involvement of TGF-β1 in fibro-
sis is widely described, this growth factor may have dual 
effects on arthritic diseases [47]. Both immune cells and 
fibroblasts are part of the complex microenvironments 
that underlie AL and OA and in which TGF-β1 may have 
different effects depending on levels of other inflammatory 
mediators. Additionally, in the context of particle-induced 
immune response, TGF-β1 has a conjoint role with other 
factors on bone remodeling [12].
Moreover, previous studies demonstrated that serum 
TGF-β1 has not predictive value to assess OA incidence 
and progression [48, 49]. In our study, despite the differ-
ence in tissues regarding TGF-β1, AL and OA patients pre-
sented similar concentrations of TGF-β1 in serum.
The crosstalk between inflammation and innervation 
has been widely investigated in several joint-related dis-
orders but not in presence of prostheses [50, 51]. Pre-
vious studies have reported sensory and sympathetic 
innervation in joints diseases namely OA and rheumatoid 
arthritis (RA), where an inflammatory response is taken 
place within synovial tissues or in the vicinity of the artic-
ulation. Our study demonstrated for the first time dis-
tinct pattern of sensory and sympathetic innervation in 
AL patients characterized by a loss of sympathetic nerve 
fibers when compared to OA patients. This differential 
profile has been also described in a comparative study 
showing lack of sympathetic innervation in RA patients 
while in OA patients this does not occur [52]. The 
authors suggested that the reduction or absence of sym-
pathetic innervation might be a consequence of the initial 
synovial inflammation, probably involving nerve repel-
lent molecules [53], and a key factor to its maintenance 
in RA. In AL, a sustained chronic inflammatory response 
is maintained by the presence of prosthetic debris, pri-
marily generated at the bearing surface of hip prostheses. 
Therefore, our findings, supported by those described 
in RA, strongly indicate a close correlation between 
sympathetic innervation pattern and the degree of the 
inflammatory response. A previous study described the 
appearance of TH+ cells in the collagen-induced arthritis 
in mice and hypothesized that the presence of those cells 
might be a compensatory mechanism to the deprivation 
of sympathetic neurotransmitters in the joint [54]. In AL 
patients, TH+ catecholamine-producing cells were not 
detected in the synovial membrane-like interface, sug-
gesting total uncoupling of local joint inflammation from 
the sympathetic activity (nerve fibers and cells).
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Several animal and human studies have addressed the 
pattern of the sensory innervation in arthritis, namely 
in OA, and reported a significant re-organization of the 
sensory nerve fibers characterized by an alteration in the 
morphology, density and sprouting into areas of the joint 
that are normally poorly innervated [21]. In this study we 
showed that there is also alteration in the sensorial inner-
vation of synovial membrane-like interface tissues in AL 
patients with a notable distinct tissue distribution when 
compared to OA. SP and CGRP immunoreactive nerve 
fibers were observed in subintima regions (outer layer) 
mainly around blood vessels while in AL they were dis-
tributed throughout synovial membrane-like interface 
tissues. Of note, SP+ and CGRP+ cells were also found 
in these tissues as an additional source of these neuro-
peptides. Although, SP and CGRP are recognized as 
neuro-inflammatory modulators in arthritic joints, their 
functional role in the inflammatory response associated 
to prosthetic debris as well as in the reorganization of sen-
sory and sympathetic nerve fibers in inflamed joint need 
to be clarified.
We acknowledge certain limitations in this study. To 
study the differences between AL and OA, thirty-five 
patients were included in our study, an average number 
in the field [40]. OA synovial tissues and synovial mem-
brane-like interface tissues were retrieved by the same 
surgeon to minimize location bias. The histological semi-
quantification of accumulation of prosthetic debris in 
aseptic interface tissues was limited to micro-sized par-
ticles, or clusters of nanoparticles, although tissues have 
been previously evaluated by SEM. Gene expression anal-
ysis was successfully performed in eleven out of twenty 
AL patients due to low RNA quality. Patients’ stratifi-
cation concerning implant fixation and metallosis (AL 
group) or disease severity (OA group) was performed but 
no significant effect was identified. On the other hand, 
the interpretation of the variability between patients may 
not be just influenced by a specific biological response in 
joint region but by other factors such as patients comor-
bidities (e.g. diabetes mellitus and dyslipidemia), geriatric 
condition, or genetic susceptibility to AL [16, 55].
Conclusions
Overall this study showed that AL and OA are two joint 
pathologies characterized by local immune response 
however with distinct tissue organization and immune 
cell distribution. This differential immune profile is also 
accompanied with changes of sensory and sympathetic 
innervation in hip joint. These findings highlight that the 
interplay between inflammation and innervation may be 
joint pathology-specific. Therefore, a deeper and conjoint 
understanding of these processes will constitute a solid 
base for targeted-therapies to improve hip joint lifetime 
and treatment.
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